tiprankstipranks
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress ReleasesViking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
11d ago
Viking Therapeutics options imply 8.8% move in share price post-earnings
PremiumThe Fly
Viking Therapeutics options imply 8.8% move in share price post-earnings
11d ago
Viking Therapeutics management to meet virtually with Truist
PremiumThe Fly
Viking Therapeutics management to meet virtually with Truist
13d ago
Viking Therapeutics price target raised to $138 from $116 at Oppenheimer
PremiumThe FlyViking Therapeutics price target raised to $138 from $116 at Oppenheimer
1M ago
Viking (NASDAQ:VKTX): Positive Trial Data Boosts Stock
PremiumMarket News
Viking (NASDAQ:VKTX): Positive Trial Data Boosts Stock
1M ago
Viking Therapeutics price target raised to $138 from $116 at Oppenheimer
PremiumThe Fly
Viking Therapeutics price target raised to $138 from $116 at Oppenheimer
1M ago
Viking Therapeutics reports Phase 1 results of VK2735 in obesity
PremiumThe FlyViking Therapeutics reports Phase 1 results of VK2735 in obesity
1M ago
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
PremiumThe Fly
Approval of Madrigal’s Rezdiffra positive for Viking and MASH space, says Stifel
2M ago
Viking Therapeutics price target raised to $100 from $86 at BTIG
PremiumThe Fly
Viking Therapeutics price target raised to $100 from $86 at BTIG
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100